How AI Can Reshape Access To Specialty Medications
Briefly

Philip Zimbardo's experiment in 1969 illustrated how environmental neglect can lead to systemic decline, exemplified by the decay of an abandoned car. The author likens prior authorizations for specialty medications to this phenomenon, highlighting how outdated, manual processes drain resources and frustrate providers. This inefficiency often impacts patient treatment, particularly for those awaiting critical medications. However, with advancements in AI, the healthcare industry has new tools to streamline and enhance these processes, ensuring timely patient care and reducing administrative burdens for providers.
In today's healthcare landscape, we face a broken window in the form of outdated prior authorization processes that burden both providers and patients.
AI has the potential to revolutionize prior authorizations by automating processes, improving efficiency, and ensuring patients receive timely treatments they need.
Read at Forbes
[
|
]